Improving patient outcomes during surgery and anesthesia
Safe Brain Initiative - Dedicated to Advancing Anaesthesia and Perioperative Personalised Care Towards Precision Anaesthesia Care. A Continuous Quality Improvement Initiative.
This study is testing ways to make surgery safer and help patients recover better by reducing side effects like confusion and memory problems after anesthesia.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 15000 (estimated) |
| Ages | 18 Years to 100 Years |
| Sex | All |
| Sponsor | University of Southern Denmark Academic / other |
| Locations | 1 site (Nykøbing Falster) |
| Trial ID | NCT05765162 on ClinicalTrials.gov |
What this trial studies
The Safe Brain Initiative aims to monitor and reduce adverse side effects associated with surgery and anesthesia, such as postoperative delirium and neurocognitive disorders. By implementing 18 core non-invasive recommendations, the initiative seeks to guide clinicians towards the least invasive and least side effect-prone pathways during the perioperative process. The study will utilize patient-reported outcomes and provide structured feedback to healthcare professionals to enhance care quality and operational efficiency in the operating room. This approach is designed to ultimately improve patient well-being and reduce long-term cognitive impairments.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older undergoing surgical procedures.
Not a fit: Patients under the age of 18 will not benefit from this study.
Why it matters
Potential benefit: If successful, this initiative could significantly enhance the quality of care for surgical patients, reducing complications and improving recovery outcomes.
How similar studies have performed: Other studies have shown success in implementing structured feedback systems to improve patient outcomes in surgical settings, indicating that this approach has potential.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: • All patients from age ≥18 Exclusion Criteria: • All patients from age \<18
Where this trial is running
Nykøbing Falster
- Nykøbing Falster Hospital — Nykøbing Falster, Denmark (Recruiting)
Study contacts
- Principal investigator: Finn M. Radtke, Professor — University of Southern Denmark
- Study coordinator: Finn M. Radtke, Professor
- Email: finnmradtke@me.com
- Phone: +4915127067901
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.